Abstract:Introduction Resident colonic bacteria (anaerobes and firmicutes) ferment undigested fibre. The balance between their large species number is influenced by the host genetic make up. An individuals “fermentation profile” (FP) is therefore likely to comprise a stable “personal signature” and a variable portion, which is influenced by the gut environment—diet and to a lesser extent drugs, thus offering an insight into colonic microbial health. A method of monitoring FP is by analysing the gaseous release that emanates off a patient9s urine or faecal sample. This can then be characterised using various techniques, but two options are: Artificial olfaction (the so called electronic nose or e-nose), which offers a method to rapidly identify disease groups based on the a complete “bio-odorant signature”; Gas Chromatography/Mass Spectrometry, which seeks to identify all the chemical components within a sample. Aim Pilot study using an “e-nose” to determine if disease groups can be distinguished and identified from faeces and urine samples. Methods Subjects and patients: two healthy (normal) volunteers; Ulcerative Colitis (n=1; active disease induced into remission), Crohns Disease (n=1). Biological samples of faeces and urine were collected and urine samples were analysed. Samples were prepared in universal containers (10 ml) and heated to 38±0.1°C. The headspace (the air above the sample) was then analysed using a Cyrano A320 (Smith Detection) e-nose, employing 32 carbon black compositae chemoresistive chemical sensors. These instruments employ a series of sensors with overlapping sensitivity, thus creating a “fingerprint” of the total chemical composition of a sample (as with the human nose). Each headspace was sampled for 30 s, and purged for a further 30 s in laboratory air. The differential response between the sample and the background air was used for analysis. Results The PCA plot generated (not shown; high resolution) demonstrates the e-nose9s capability to distinguish between disease groups with >90% selectivity. Specifically there was polarity between UC and CD subjects and importantly, shifting of profile in the UC subject with treatment towards a normal configuration. Conclusion 1. The e-nose offers a rapid and promising way of investigating FPs in health and disease. 2. Clear differences in gaseous profile between volunteers and disease subjects were demonstrated. 3. The gaseous profile changes with treatment. The study of FPs using e-nose is novel and offers a new insight into “scenting” gut health.

Using infrared gas sensors in an in-vitro dynamic gut model for detecting short-chain fatty-acids: Technical Report

Real-Time Non-Invasive Monitoring of Short-Chain Fatty Acids in Exhaled Breath

Development and Validation of a LC-MS/MS Technique for the Analysis of Short Chain Fatty Acids in Tissues and Biological Fluids without Derivatisation Using Isotope Labelled Internal Standards

A Gas Chromatography Mass Spectrometry-Based Method for the Quantification of Short Chain Fatty Acids

Quantifying Gut Microbial Short-Chain Fatty Acids and Their Isotopomers in Mechanistic Studies Using a Rapid, Readily Expandable LC-MS Platform

Simple, high-throughput measurement of gut-derived short-chain fatty acids in clinically relevant biofluids using gas chromatography-mass spectrometry

Detection of volatile fatty acids in anaerobic digestion system by near infrared spectroscopy

T1267 the Gut in Health and Disease: Scenting the Difference by ‘electronic Nose’

Quantitation of circulating short-chain fatty acids in small volume blood samples from animals and humans

Toward a Hybrid Biosensor System for Analysis of Organic and Volatile Fatty Acids in Fermentation Processes

Rapid Determination of Short-Chain Fatty Acids in Colonic Contents and Faeces of Humans and Rats by Acidified Water-Extraction and Direct-Injection Gas Chromatography

In vitro gastrointestinal gas monitoring with carbon nanotube sensors

Non-invasive VOCs detection to monitor the gut microbiota metabolism in-vitro

The Potential of Bioelectrochemical Sensor for Monitoring of Acetate During Anaerobic Digestion: Focusing on Novel Reactor Design

Electrochemical biosensor for aerobic acetate detection

Model-based mid-infrared spectroscopy for on-line monitoring of volatile fatty acids in the anaerobic digester

Gut in tube – continuous measurement of metabolic crosstalk between gut microbiota and colonocytes by NMR imaging

On-line analysis and in situ pH monitoring of mixed acid fermentation by Escherichia coli using combined FTIR and Raman techniques

The optimization and validation of a gas chromatography-mass spectrometry method to analyze the concentration of acetate, propionate and butyrate in human plasma or serum

A Multi-Sensor Mini-Bioreactor to Preselect Silage Inoculants by Tracking Metabolic Activity in situ During Fermentation

Innovative Air-Cathode Bioelectrochemical Sensor for Monitoring of Total Volatile Fatty Acids During Anaerobic Digestion.